Steve Kirsch

• 

  'In Discussion With'

  Testing and using drug treatment during a pandemic

  Written by Christine Clark | 10 Jun 2021

  Interview and article by Christine Clark. Steve Kirsch, CEO of the Covid-19 Early Treatment Fund (CETF) explains how a study in Nepal will advance our understanding of effective… read more.

• 

  'In Discussion With'

  Treatment of covid-19 with ivermectin + fluvoxamine combination

  Written by Christine Clark | 9 Jun 2021

  Interview and article by Christine Clark. A combination of fluvoxamine and ivermectin for early treatment of covid-19 is highly effective and should be implemented widely, according to Steve… read more.

• 

  'In Discussion With'

  Fluvoxamine for early treatment of covid-19

  Written by Christine Clark | 8 Jun 2021

  Article by Christine Clark. Evidence from trials and real world experience shows that selective serotonin reuptake inhibitors (SSRIs) are effective in treating acute covid and preventing long-haul covid.

• 

  'In Discussion With'

  Trials of fluvoxamine for covid-19

  Written by Christine Clark | 8 Jun 2021

  Interview and article by Christine Clark. Early treatment of covid-19 with fluvoxamine has been remarkably effective in two trials, one of which was funded by the Covid-19 Early… read more.